DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sheel Biotech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·14 Oct 2026, 10:19 am

Sheel Biotech

Sheel Biotech Limited has informed stock exchanges that it has obtained a certificate under SEBI's (Depositories and Participants) Regulations, 2018. This document confirms that the company is fully compliant with the regulatory framework governing shareholding patterns and depository operations.

This compliance is a routine but essential requirement for listed companies. It ensures that the company’s shareholding structure is accurate and transparent, which is vital for maintaining market integrity. For investors, this update signals that the company is following standard governance protocols without any immediate red flags.

Investors should treat this as a standard regulatory filing rather than a major market-moving event. The stock is likely to see no significant price reaction. Going forward, it is prudent to focus on the company’s core business performance and upcoming financial results for any meaningful trends.